Women's satisfaction with and ongoing use of hormonal long-acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd).
adverse effect
contraception
contraceptive method
long-acting reversible contraception
patient satisfaction
Journal
The Australian & New Zealand journal of obstetrics & gynaecology
ISSN: 1479-828X
Titre abrégé: Aust N Z J Obstet Gynaecol
Pays: Australia
ID NLM: 0001027
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
23
10
2020
accepted:
05
01
2021
pubmed:
19
2
2021
medline:
30
6
2021
entrez:
18
2
2021
Statut:
ppublish
Résumé
The Australian Contraceptive ChOice pRoject (ACCORd) aimed to assess the impact of a complex general practice intervention on the uptake of long-acting reversible contraceptives (LARC). Using survey data from enrolled women, we aimed to compare the ongoing use and satisfaction of women who chose one of the hormonal LARC methods including the levonorgestrel intrauterine system (LNG-IUS) or levonorgestrel implant compared to the oral contraceptive pill (OCP). We used the data from participants' baseline, six and 12-month surveys to identify new users of implants, LNG-IUS or OCP. We included demographic information, ongoing use of the contraceptive method, reasons for dissatisfaction and discontinuation and experience of side-effects. Proportions were compared using χ Of the 740 women enrolled in ACCORd, 176 started using a hormonal LARC or OCP in the study's first six months with 76 using the IUS (43%), 60 the implant (34%) and 40 (23%) the OCP. Twelve-month continuation rates for the LNG-IUS, implant and OCP were 93, 83 and 65% respectively (P < 0.001). Satisfaction was highest among the LNG-IUS users; 86% were very/somewhat satisfied compared to 75% of implant users and 61% of OCP users (P < 0.001). Main reasons for method dissatisfaction were irregular bleeding and mood changes which were similar for all methods. This study provides further evidence that hormonal LARC methods have higher continuation and satisfaction rates compared to the OCP with similar side-effects. Since hormonal LARC methods have the highest contraceptive efficacy, these should be offered first-line to women.
Sections du résumé
BACKGROUND
The Australian Contraceptive ChOice pRoject (ACCORd) aimed to assess the impact of a complex general practice intervention on the uptake of long-acting reversible contraceptives (LARC).
AIMS
Using survey data from enrolled women, we aimed to compare the ongoing use and satisfaction of women who chose one of the hormonal LARC methods including the levonorgestrel intrauterine system (LNG-IUS) or levonorgestrel implant compared to the oral contraceptive pill (OCP).
MATERIALS AND METHODS
We used the data from participants' baseline, six and 12-month surveys to identify new users of implants, LNG-IUS or OCP. We included demographic information, ongoing use of the contraceptive method, reasons for dissatisfaction and discontinuation and experience of side-effects. Proportions were compared using χ
RESULTS
Of the 740 women enrolled in ACCORd, 176 started using a hormonal LARC or OCP in the study's first six months with 76 using the IUS (43%), 60 the implant (34%) and 40 (23%) the OCP. Twelve-month continuation rates for the LNG-IUS, implant and OCP were 93, 83 and 65% respectively (P < 0.001). Satisfaction was highest among the LNG-IUS users; 86% were very/somewhat satisfied compared to 75% of implant users and 61% of OCP users (P < 0.001). Main reasons for method dissatisfaction were irregular bleeding and mood changes which were similar for all methods.
CONCLUSIONS
This study provides further evidence that hormonal LARC methods have higher continuation and satisfaction rates compared to the OCP with similar side-effects. Since hormonal LARC methods have the highest contraceptive efficacy, these should be offered first-line to women.
Substances chimiques
Contraceptive Agents, Female
0
Levonorgestrel
5W7SIA7YZW
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
448-453Informations de copyright
© 2021 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Références
Brucker C, Karck U, Merkle E. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing: results of clinical experience in Germany. Eur J Contracept Reprod Health Care 2008; 13(1): 31-38.
Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998; 179(Pt 1): 577-582.
Inoue K, Barratt A, Richters J. Does research into contraceptive method discontinuation address women's own reasons? A critical review. J Fam Plann Reprod Health Care 2015; 41(4): 292-299.
Peipert JF, Zhao Q, Allsworth JE et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011; 117: 1105-1113.
Diedrich JT, Zhao Q, Madden T et al. Three-year continuation of reversible contraception. Am J Obstet Gynecol 2015; 213: 662.e661-668.
Secura GM, Allsworth JE, Madden T et al. The contraceptive CHOICE project: reducing barriers to long-acting reversible contraception. Am J Obstet Gynecol 2010; 203(2): 115.e111-117.
Burke HM, Packer CA, Spector HL, Hubacher D. Opportunity, satisfaction, and regret: trying long-acting reversible contraception in a unique scientific circumstance. Women Health 2019; 59(3): 266-280.
Winner B, Peipert JF, Zhao Q et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012; 366: 1998-2007.
Richters J, Fitzadam S, Yeung A et al. Contraceptive practices among women: the second Australian study of health and relationships. Contraception 2016; 94: 548-555.
Cea-Soriano L, Garcia Rodriguez LA, Machlitt A, Wallander MA. Use of prescription contraceptive methods in the UK general population: a primary care study. BJOG 2014; 121(1):53-60; discussion 60-51.
Institute G. Contraceptive Use in the United States, 2018. [Accessed 22 February 2019.] Available from URL: https://www.guttmacher.org/fact-sheet/contraceptive-use-united-states
Mazza D, Harrison C, Taft A et al. Current contraceptive management in Australian general practice: an analysis of BEACH data. Med J Aust 2012; 197(2): 110-114.
Mazza D, Black K, Taft A et al. Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol. BMJ Open 2016; 6(10): e012491.
Mazza D, Watson CJ, Taft A et al. Increasing long-acting reversible contraceptives: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized trial. Am J Obstet Gynecol 2020;222(4):S921.e921-S921.e913.
The Consort Group, 2019. [Accessed 20 December 2019.] Available from URL: http://www.consort-statement.org/
Borges ALV, Santos OAd, Araújo KS et al. Satisfaction with the use of contraceptive methods among women from primary health care services in the city of São Paulo, Brazil. Rev Bras Saúde Mater Infant 2017; 17: 749-756.
Simmons RG, Sanders JN, Geist C et al. Predictors of contraceptive switching and discontinuation within the first 6 months of use among highly effective reversible contraceptive initiative Salt Lake study participants. Am J Obstet Gynecol 2019; 220: 376.e371-376.e312.
Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception 2011; 84: 478-485.
Mazza D, Bateson D, Frearson M et al. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: an expert roundtable discussion. Aust N Z J Obstet Gynaecol 2017; 57(2): 206-212.
Middleton AJ, Naish J, Singer N. General practitioners' views on the use of the levonorgestrel-releasing intrauterine system in young, nulligravid women, in London, UK. Eur J Contracept Reprod Health Care 2011; 16: 311-318.
Wellings K, Zhihong Z, Krentel A et al. Attitudes towards long-acting reversible methods of contraception in general practice in the UK. Contraception 2007; 76(3): 208-214.
Goldhammer DL, Fraser C, Wigginton B et al. What do young Australian women want (when talking to doctors about contraception)? BMC Fam Pract 2017; 18(1): 35.
Nelson AL, Cohen S, Galitsky A et al. Women's perceptions and treatment patterns related to contraception: results of a survey of US women. Contraception 2018; 97(3): 256-273.